Guangdong Dtech Technology (01377): Plans to uniformly adopt the Chinese Accounting Standards for preparing financial reports and terminate the appointment of overseas financial reporting audit institutions.
Ding Tai Gao Ke (01377) announced that in order to improve the efficiency of information disclosure, simplify the financial preparation process, and save on disclosure costs and audit fees, the company proposes to only adopt and prepare financial statements in accordance with Chinese Accounting Standards to disclose the companys performance for the year ending December 31, 2026, and for subsequent accounting years, and to disclose this information in mainland China and the Hong Kong market.
In this regard, the company proposes to terminate the appointment of RSM Hong Kong as the auditor for the company's overseas financial report for the year 2026.
Guangdong Dtech Technology (01377) announced that in order to improve the efficiency of information disclosure, simplify the financial preparation process, and save on disclosure and audit costs, the company proposes to adopt and prepare financial statements in accordance with Chinese Accounting Standards for the fiscal year ending December 31, 2026, and subsequent accounting years, and to disclose these in the mainland China and Hong Kong markets.
In this regard, the company proposes to terminate the appointment of RSM Hong Kong as the overseas financial report audit institution for the year 2026.
Related Articles
.png)
Jiangsu Hengrui Pharmaceuticals (01276) plans to adopt the H-share stock plan for 2026.

US Stock Market Move | Estee Lauder Companies Inc. Class A (EL.US) surged over 17% as its fourth fiscal quarter results exceeded expectations.

Jiangsu Hengrui Pharmaceuticals (01276) recommends adopting the 2026 A-share employee stock ownership plan.
Jiangsu Hengrui Pharmaceuticals (01276) plans to adopt the H-share stock plan for 2026.
.png)
US Stock Market Move | Estee Lauder Companies Inc. Class A (EL.US) surged over 17% as its fourth fiscal quarter results exceeded expectations.

Jiangsu Hengrui Pharmaceuticals (01276) recommends adopting the 2026 A-share employee stock ownership plan.

RECOMMEND





